Go to deals
Consumer & Retail | Healthcare

VIP Petcare has been acquired by PetIQ, Inc.

The owners of VIP Petcare (VIP), a leading veterinary services provider, have sold the company to PetIQ, Inc. for US$220 million.

VIP is a nationwide provider of veterinary wellness services through more than 2,900 community clinics hosted at local pet retailers. The company also distributes pet wellness products.

PetIQ (NASDAQ: PETQ), a distributor and manufacturer of pet medications, is the leading seller to the retail channel of pet products that were previously available for purchase primarily from veterinary clinics.

One of Oaklins' teams in the USA served as the exclusive financial advisor to the seller in this transaction.

Parties

Talk to the deal team

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

John Dean

Managing Director
Atlanta, United States
Oaklins TM Capital

James McLaren

Managing Director
New York, United States
Oaklins TM Capital

Related deals

MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more
SLT has been acquired by Indutrade
Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more